This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Sascha Hartmann: Innovator in Dementia Treatment
Introduction
Sascha Hartmann is a notable inventor based in Braintree, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia. His innovative work focuses on compounds that can potentially alter the course of Alzheimer's disease and related conditions.
Latest Patents
Sascha Hartmann holds a patent for "Piperidines and related compounds for the treatment of dementia." This patent describes compounds of formula I that modulate the action of gamma secretase, which is crucial in the treatment of Alzheimer's disease. His research aims to provide new therapeutic options for patients suffering from this debilitating condition.
Career Highlights
Sascha is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role involves extensive research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for complex health issues.
Collaborations
Throughout his career, Sascha has collaborated with talented professionals, including Joanne Clare Hannam and Andrew Madin. These partnerships have enhanced his research efforts and contributed to the advancement of his projects.
Conclusion
Sascha Hartmann's work in developing compounds for dementia treatment exemplifies the impact of innovation in healthcare. His contributions are vital in the ongoing fight against Alzheimer's disease, showcasing the importance of research and collaboration in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile